Stem cell startup Aldagen earns CEO Cancer ‘Gold Standard’
Aldagen
Related Blog Posts
On The Web
Site Search
Get the latest news alerts: Follow LTW at Twitter.
Local Tech Wire
CARY, N.C. - Aldagen, a startup focused on stem cell therapies and technology, is the latest company to receive accreditation from the CEO Roundtable on Cancer.
The Cary-based non-profit group honors companies that take steps to reduce cancer risks among their employees and families with the CEO Cancer Gold Standard.
“Our Gold Standard recognizes that Aldagen’s work in developing novel biopharmaceuticals to improve health begins with a commitment to provide world-class health and wellness benefits for its employees and their family members,” said William Weldon, chairman of the CEO Roundtable.
To receive the accreditation, companies must take steps to discourage tobacco use, encourage physical activity, promote healthy diet, encourage tests for early cancer detection and support participation in clinical trials.
Other Triangle area accredited companies include Duke Medicine, GlaxoSmithKline, Pharmaceutical Product Development, Quintiles and SAS.
Copyright 2010 Local Tech Wire. All rights reserved.
Featured
E-mail Preferences
The Skinny
- Consumers spending more online; 43% say economy is improving
- PC demand slackens – Another bad sign for tech
- Tobacco Road redrawn: ‘Brainiest' survey relocates UNC and NCSU - temporarily
- PE Hub writer prepares to launch new venture – The Term Sheet
- Cisco may be dialing up a Skype acquisition
- 40% of employees say IT security is too tough
- Cyberwar: Intel agency invades Pentagon with a flash drive
- Does a Red Hat buyout make sense?
- Red Hat takeover talk heats up ahead of press conference
- What is N.C's real jobless rate? Try 17.8%